|
|
Issue
|
Alert me when new journal issues are available via  or via  |
|
|
| Journal of Clinical Virology |
| Volume 36, Supplement 2 (2006) |
|
Search Within This Issue
|
|
|
|
|
|
|
|
|
|
|
Foreword
page iii
Full-Text PDF (49 KB)
|
|
|
Oral Presentations
|
|
|
PL01 - HAV and HEV: Epidemiology, Virology, Immunology, Natural History, Vaccines, Treatment
|
|
O.001 Hepatis A: molecular virology and pathogenesis
A. Martin
page S1
Full-Text PDF (122 KB)
|
|
O.003 Hepatitis E: light at the end of the tunnel?
R.H. Purcell
page S1
Full-Text PDF (122 KB)
|
|
O.004 Elements of pathogenesis and natural history of HEV infection
K. Krawczynski
page S1
Full-Text PDF (122 KB)
|
|
O.005 Protection against hepatitis E by a recombinant vaccine
M.P. Shrestha, R. McNair Scott, D.M. Joshi, M.P. Mammen, G.B. Thapa, N. Thapa, K.S. Aye Myint, M. Fourneau, R.A. Kuschner, S.K. Shrestha, M.P. David, J. Seriwatana, D.W. Vaughn, A. Safary, T.P. Endy, B.L. Innis
page S2
Full-Text PDF (143 KB)
|
|
|
PS01 - Hepatitis delta
|
|
O.006 Characterization of RNA-directed transcription of human hepatitis delta virus RNA
J.M. Taylor, X. Nie, J. Chang
page S2
Full-Text PDF (143 KB)
|
|
O.007 The HDV/HepaRG model for in vitro analysis of the HBV envelope protein functions at viral entry
C. Sureau, G. Abou-Jaoudé, O. Hantz, C. Trépo
page S2
Full-Text PDF (143 KB)
|
|
O.008 Cytoplasm-localized large hepatitis delta antigen interferes clathrin-mediated protein trafficking
C. Huang, S.C. Chang, I.C. Yu, Y.G. Tsay, M.F. Chang
pages S2-S3
Full-Text PDF (275 KB)
|
|
O.009 HDV-WHV genotypes and outcome of superinfection in woodchuck model
E. D'Ugo, S. Orobello, A. Canitano, R. Giuseppetti, G. Palmieri, C. Argentini, M. Rapicetta
page S3
Full-Text PDF (137 KB)
|
|
O.010 Peculiar fulminant HDV hepatitis in Amazonia
R. Paraná
page S3
Full-Text PDF (137 KB)
|
|
|
PS02 - Vaccines and immune response
|
|
O.012 Cross-reactive epitopes identified in hepatitis C virus envelope proteins induce antibodies that capture virions from infected patients' sera and neutralize HCV/HIV pseudotypes
L. Grollo, J. Torresi, A.E. Fischer, H. Drummer, W. Zeng, D.C. Jackson
page S4
Full-Text PDF (135 KB)
|
|
O.013 Potent T-cell immunity induced by a hepatitis C virus candidate vaccine based on a non-replicative poxvirus
G.J. Inchauspe, A. Fournillier, E. Gerossier, A. Evlachev, P. Martin, L. Chafel, D. Schmidt, N. Silvestre
page S4
Full-Text PDF (135 KB)
|
|
O.014 Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects
M.L. Michel, A. Pajot, M.N. Ungeheuer, D.M. Ojcius, F.A. Lemonnier, Y.C. Lone
page S4
Full-Text PDF (135 KB)
|
|
O.015 A phase 1 trial of a novel E1E2/MF59C.1 hepatitis C vaccine candidate in healthy HCV-negative adults (DMID 01-002)
S.E. Frey, G.J. Gorse, A.M. DiBisceglie, D. Rosa, Z. Stamataki, J. McKeating, R. Ray, S. Coates, V. Schultze, S. Abrignan, M. Houghton, H. Hill, R.B. Belshe
page S5
Full-Text PDF (136 KB)
|
|
O.016 Towards effective prophylactic and therapeutic vaccination against HCV
A. Folgori
page S5
Full-Text PDF (136 KB)
|
|
|
PS03 - HBV: Animal and celullar models
|
|
O.017 Primary and secondary occult hepadnaviral infections: identification and differential characteristics
T.I. Michalak, P.M. Mulrooney-Cousins, C.S. Coffin, T.N.Q. Pham, S.A. Gujar
pages S5-S6
Full-Text PDF (275 KB)
|
|
O.018 Therapeutic vaccination in chronic hepatitis B: pre-clinical studies in the woodchuck
M. Roggendorf, M. Lu
page S6
Full-Text PDF (144 KB)
|
|
O.019 Expansion of HBV S gene heterogeneity in chimpanzees after experimental inoculation with HBV sT126N mutant
A. Araujo, J. Yokosawa, J. Spelbring, V. Tzaneva, S. Kamili, K. Krawczynski, H. Fields, Y. Khudyakov
page S6
Full-Text PDF (144 KB)
|
|
O.020 HBV/HCV: Animal/cellular models
J. Petersen
page S6
Full-Text PDF (144 KB)
|
|
O.021 Determinants of infectivity in the antigenic loop of hepatitis B virus envelope proteins
G. Abou Jaoudé, C. Sureau
pages S6-S7
Full-Text PDF (287 KB)
|
|
O.022 Hepatitis B virus infection is dependent on a multistep attachment and entry process mediated by the preS1 and the S-domain
D. Glebe, S. Grün, C. Leistner, A. Bulavaite, K. Sasnauskas, W.H. Gerlich
page S7
Full-Text PDF (147 KB)
|
|
|
PS04 - Bloodborne viruses, blood transfusion, organ transplantation
|
|
O.023 Transfusion associated hepatitis B virus infections
P.V. Holland
page S7
Full-Text PDF (147 KB)
|
|
O.024 Recent insights into HCV natural history and pathogenesis from studies of infected blood donors and recipients
M.P. Busch
pages S7-S8
Full-Text PDF (282 KB)
|
|
O.025 Full-length preS1-preS2-HBs antigen (HBsAg) sequence analysis of HBV surface mutants in HBV DNA-positive organ, tissue and cell donors with various HBV serological profiles
S. Chevaliez, D. Challine, R. Brillet, J. Pawlotsky
page S8
Full-Text PDF (138 KB)
|
|
O.026 Vaccination against hepatitis B in liver transplant recipients with history of hepatitis B infection: analysis of cellular immune response shows evidence of HBsAg specific regulatory T cells
T. Bauer, M. Günther, U. Bienzle, W. Jilg
page S8
Full-Text PDF (138 KB)
|
|
O.027 Broad reactivity of two anti-E2 human monoclonal antibodies against HCV quasispecies after liver transplantation
O. Nussbaum, D. Landstein, R. Eren, S. Dagan
page S8
Full-Text PDF (138 KB)
|
|
|
PS05 - HAV and HEV: Basic research, development of new vaccines
|
|
O.028 The HEV ORF3 protein downregulates the mitochondrial death pathway through increased expression and oligomerization of VDAC
S.M. Moin, M. Panteva, S. Jameel
page S9
Full-Text PDF (145 KB)
|
|
O.029 Analysis of hepatitis E virus mutants in a new cell culture system
S.U. Emerson, H. Nguyen, U. Torian, R.H. Purcell
page S9
Full-Text PDF (145 KB)
|
|
O.030 Hepatitis E virus ORF2 and ORF3 proteins are encoded by a bicistronic subgenomic mRNA
J. Graff, U. Torian, H. Nguyen, S. Emerson
pages S9-S10
Full-Text PDF (285 KB)
|
|
O.031 Enhanced alpha-1 microglobulin secretion from hepatitis E virus ORF3 expressing human hepatoma cells is mediated by the tumor susceptibility gene 101
S.K. Lal, M. Surjit, R. Oberoi, R. Kumar
page S10
Full-Text PDF (143 KB)
|
|
O.032 Sequential saliva testing used in the investigation of a hepatitis A outbreak, Auvergne (France), December 2004
P. Santa-Olalla, A. Roque-Afonso, B. Cottrelle, V. Mackiewicz, E. Couturier, J. Beytout, E. Dussaix, E. Delarocque-Astagneau
page S10
Full-Text PDF (143 KB)
|
|
O.033 Outbreaks of hepatitis A in western India: 2002–2004
M.S. Chadha, J. Ramakrishnan, K.S. Lole, A.C. Mishra, V.A. Arankalle
page S10
Full-Text PDF (143 KB)
|
|
|
PL02 - Epidemiology of HBV, HDV and HCV
|
|
O.034 Emerging infections that threaten the blood supply
H.J. Alter
page S11
Full-Text PDF (145 KB)
|
|
O.035 Hepatitis B virus infection 25 years after the development of an effective vaccine
A. Mele
page S11
Full-Text PDF (145 KB)
|
|
O.037 Prediction of HCV-related morbidity and mortality burden in France using the back-calculation method
S. Deuffic-Burban, J.B. Wong, A.-J. Valleron, T. Poynard
pages S11-S12
Full-Text PDF (276 KB)
|
|
O.038 The importance of surveillance for the management of viral hepatitis
D. Lavanchy
page S12
Full-Text PDF (135 KB)
|
|
|
PS06 - Molecular and clinical HBV epidemiology
|
|
O.039 Molecular tools in epidemiological investigations
L.O. Magnius
page S12
Full-Text PDF (135 KB)
|
|
O.040 Classification of hepatitis B virus genotypes into higher-order genetic groups
M.A. Purdy, A.C. Gonzales, Z. Dimitrova, Y. Khudyakov
pages S12-S13
Full-Text PDF (273 KB)
|
|
O.041 Molecular signature motifs of HBV subgenotypes: An analysis based on all open reading frames
H. Norder, L. Magnius
page S13
Full-Text PDF (141 KB)
|
|
O.042 The added value of molecular analysis in the source and contact tracing of hepatitis B transmission in a community
M. Mostert, R.R.A. De Man, B.H.G.M. Niesters, G.G.J.J. Van Doornum, H.H.M. Götz, J.J.H. Richardus
page S13
Full-Text PDF (141 KB)
|
|
O.043 Incidence of acute hepatitis B in the USA, 1990–2005
L. Finelli, A. Wasley, B.P. Bell
pages S13-S14
Full-Text PDF (272 KB)
|
|
O.044 Hepatitis B epidemiology and prevention: where are we in Europe in 2006
P. Van Damme
page S14
Full-Text PDF (134 KB)
|
|
|
PS07 - HBV: Clinical trials
|
|
O.045 Chronic hepatitis B: When to institute treatment
J. Heathcote
page S14
Full-Text PDF (134 KB)
|
|
O.046 Treatment of hepatitis B e antigen positive disease
G.K.K. Lau
pages S14-S15
Full-Text PDF (277 KB)
|
|
O.047 Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
S.J. Hadziyannis
page S15
Full-Text PDF (148 KB)
|
|
O.048 Treatment of chronic hepatitis B with the combination of pegylated interferon with a nucleoside/nucleotide analogue
P. Marcellin
page S15
Full-Text PDF (148 KB)
|
|
O.049 Five years of sequential LAM to LAM+ADV therapy suppresses HBV replication in most HBeAg-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma
P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, M. Colombo
pages S15-S16
Full-Text PDF (288 KB)
|
|
|
PS08 - HCV: Animal and cellular models
|
|
O.051 Replication of infectious wild-type HCV in cultured human T cells
S.A. MacParland, T.N.Q. Pham, T.I. Michalak
page S16
Full-Text PDF (145 KB)
|
|
O.052 Detection of intrahepatic virus-specific T-cells in marmosets with resolved GBV-B infection
D.J. Woollard, G. Haqshenas, X. Dong, E.J. Gowans
page S16
Full-Text PDF (145 KB)
|
|
O.053 The human liver uPA-SCID mouse, a preclinical model to test anti-hepatitis C compounds
T. Vanwolleghem, P. Meuleman, R. De Vos, L. Libbrecht, T. Roskams, G. Leroux-Roels
pages S16-S17
Full-Text PDF (276 KB)
|
|
O.055 The human liver-uPA-SCID mouse: a chimeric rodent model for the study of viral hepatitis
P. Meuleman, T. Vanwolleghem, G. Leroux-Roels
page S17
Full-Text PDF (136 KB)
|
|
|
PS09 - HBV: Immunopathogenesis and natural history
|
|
O.056 Immune response and viral tolerance during chronic HBV infection
A. Bertoletti
page S17
Full-Text PDF (136 KB)
|
|
O.058 Impact of human hepatocyte MHC-class I antigen presentation on virus-specific CD8 T cell function
A.J. Gehring, P.T.F. Kennedy, D. Sun, E. Nolte-'t Hoen, S. Lim, S. Wasser, C. Selden, M.K. Maini, D.M. Davis, M. Nassal, A. Bertoletti
pages S17-S18
Full-Text PDF (276 KB)
|
|
O.059 Viral quasispecies evolution in chronic hepatitis B: new light on an old story
S.G. Lim, Y. Cheng, S. Guindon, B.L. Seet, L.Y. Lee, P. Hu, S. Wasser, T. Tan, M. Goode, A. Rodrigo
page S18
Full-Text PDF (145 KB)
|
|
O.060 The outcome of combined antiviral therapy in tolerant children with chronic hepatitis B is associated with emergence of mutations within HBV core gene immunodominant epitopes
I. Carey, M. Cavers, L. D'Antiga, Y. Ma, S. Bansal, J. Byrne, G. Mieli-Vergani, D. Vergani
page S18
Full-Text PDF (145 KB)
|
|
O.061 Lamivudine treatment for acute hepatitis B — a randomized controlled trial
S.K. Sarin, M. Kumar, S. Sathpathy, S. Hissar, R. Chauhan, R. Monga, K. Das, C. Pandey, B.C. Sharma
pages S18-S19
Full-Text PDF (274 KB)
|
|
|
PS10 - HCV combination therapy
|
|
O.062 The safety and efficacy of Viramidine® plus pegylated interferon alpha-2b versus ribavirin plus pegylated interferon alpha-2b in therapy-naïve patients infected with HCV: Phase 3 results
B. Murphy
page S19
Full-Text PDF (132 KB)
|
|
O.063 Effectiveness and tolerability of pegIntron® in combination with Rebetol® in real life: The pegIntrust study
M. Adler, B. Bastens, I. Colle, J. Delwaide, J. Henrion, Y. Horsmans, P. Michielsen, P. Golstein, J.P. Mulkay, F. Nevens, W. Van Steenbergen, P. Yap, A.M. Denys, J.P. Brasseur, H. Van Vlierberghe
page S19
Full-Text PDF (132 KB)
|
|
O.064 Antiviral treatment for hepatitis C virus infection in the real practice: A nationwide Italian experience (the PROBE study)
A. Alberti, A. Ascione, M. Colombo, A. Craxi, F. Piccinino, M. Rizzetto, M. Sarracino, T. Stroffolini, C. Iannacone
page S20
Full-Text PDF (138 KB)
|
|
O.065 Anti golgi complex antibodies during pegylated interferon therapy for hepatitis C: What does it mean?
R. Paraná, M. Schinoni, L. Codes, Z. Andrade, L.A.R. De Freitas, M. Cruz, C. Trépo
page S20
Full-Text PDF (138 KB)
|
|
|
|
|
|
|
|
